A clinically applicable molecular classification of oncocytic cell thyroid nodules
Endocrine-Related Cancer · 2023
DOI: 10.1530/erc-23-0047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Elizabeth J de Koster und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Whole chromosome instability with near-whole genome haploidization (GH) and subsequent endoreduplication is considered a main genomic driver in the tumorigenesis of oncocytic cell thyroid neoplasms (OCN). These copy number alterations (CNA) occur less frequently in oncocytic thyroid adenoma (OA) than in oncocytic carcinoma (OCA), suggesting a continuous process. The current study described the CNA patterns in a cohort of 30 benign and malignant OCN, observed using a next-generation sequencing (NGS) panel that assesses genome-wide loss of heterozygosity (LOH) and chromosomal imbalances using 1500 single-nucleotide polymorphisms (SNPs) across all autosomes and the X chromosome in DNA derived from cytological and histological samples. Observed CNA patterns were verified using multiparameter DNA flow cytometry with or without whole-genome SNP array analysis and lesser-allele intensity-ratio (LAIR) analysis. On CNA–LOH analysis using the NGS panel, GH-type CNA were observed in 4 of 11 (36%) OA and in 14 of 16 OCA (88%). Endoreduplication was suspected in 8 of 16 (50%) OCA, all with more extensive GH-type CNA ( P < 0.001). Reciprocal chromosomal imbalance type CNA, characterized by (imbalanced) chromosomal copy number gains and associated with benign disease, were observed in 6 of 11 (55%) OA and one equivocal case of OCA. CNA patterns were different between the histopathological subgroups ( P < 0.001). By applying the structured interpretation and considerations provided by the current study, CNA–LOH analysis using an NGS panel that is feasible for daily practice may be of great added value to the widespread application of molecular diagnostics in the diagnosis and risk stratification of OCN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
- Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands.
- Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, the Netherlands.
- Department of Biomedical Sciences and Humanitas Clinical and Research Centre, Department of Nuclear Medicine, Humanitas University, Milan, Italy.
ORCID-Profile: Elizabeth J de Koster, Willem E Corver, Lioe-Fee de Geus-Oei, Wim J G Oyen, Dina Ruano, Abbey Schepers, Marieke Snel, Tom van Wezel, Dennis Vriens, Hans Morreau
Zitieren
APA
de Koster, E. J., Corver, W. E., de Geus-Oei, L. F., Oyen, W. J. G., Ruano, D., Schepers, A., Snel, M., van Wezel, T., Vriens, D., & Morreau, H. (2023). A clinically applicable molecular classification of oncocytic cell thyroid nodules. Endocrine-Related Cancer. https://doi.org/10.1530/erc-23-0047
Vancouver
de Koster EJ, Corver WE, de Geus-Oei LF, Oyen WJG, Ruano D, Schepers A, et al. A clinically applicable molecular classification of oncocytic cell thyroid nodules. Endocrine-Related Cancer. 2023. doi:10.1530/erc-23-0047
BibTeX
@article{deKoster2023,
author = {de Koster, Elizabeth J and Corver, Willem E and de Geus-Oei, Lioe-Fee and Oyen, Wim J G and Ruano, Dina and Schepers, Abbey and Snel, Marieke and van Wezel, Tom and Vriens, Dennis and Morreau, Hans},
title = {A clinically applicable molecular classification of oncocytic cell thyroid nodules},
journal = {Endocrine-Related Cancer},
year = {2023},
doi = {10.1530/erc-23-0047}
}
EUVIMED